A leading-edge life sciences company in the Bay Area completed its 5-year journey from startup to IPO. KalioTek™ helped them prepare their IT security and compliance for this great accomplishment.Speak With Our Biotech IT Team
Book A Complimentary Consultation With KalioTek™ Today.
A leading-edge life sciences company in the Bay Area completed its 5-year journey from startup to IPO. KalioTek™ helped them prepare their IT security and compliance for this great accomplishment.
The company tripled their stock price! Now that is an accomplishment!
Here’s what transpired:
In early 2018 our life sciences client with leading-edge immuno-therapy technology completed its IPO and saw its stock price triple on the first day of trading!
KalioTek™ had been their sole IT team since setting up their initial office in 2013. In fact, the founding CEO had been our client in a previous startup that achieved a highly successful acquisition by a large pharmaceutical company.
Interested? Read on to learn more…
Perhaps the most noteworthy part of this story is how uneventful the IPO was for the company’s IT and security systems.
What do I mean?
Because we took such care to build the appropriate systems, controls, and processes along the way, there was no great effort or cost in these areas to prepare them to be a publicly traded company.
The IPO funds the company acquired built significant growth for them. They could now build a larger facility in preparation of tripling their employee headcount in the coming year.
Because KalioTek™ was there along the way, preparation from an IT and security perspective was a non-event.
Because we ensured critical business applications were implemented in the Cloud, and security-minded processes and procedures were put in place as a matter of course.
Some of the steps we took:
Not only was the IPO preparation simplified, but by wisely implementing systems with foresight, the life-sciences company enjoyed robust information technology and security along their entire journey. And, at a lower cost than a less-thoughtful approach.
Because they were able to go public with their IPO, our client’s business was purchased for $1.6B by a major pharmaceutical company!
KalioTek™ has the experience and knowledge to do the same for you. Contact us to learn how we can help your business in Silicon Valley.